Alkeon Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $98.8M | Buy |
1,850,934
+300,000
| +19% | +$16M | 0.16% | 44 |
|
2025
Q1 | $62.8M | Sell |
1,550,934
-210,334
| -12% | -$8.51M | 0.13% | 48 |
|
2024
Q4 | $49M | Sell |
1,761,268
-1,563,736
| -47% | -$43.5M | 0.1% | 53 |
|
2024
Q3 | $95.4M | Sell |
3,325,004
-2,216
| -0.1% | -$63.6K | 0.16% | 45 |
|
2024
Q2 | $78.1M | Hold |
3,327,220
| – | – | 0.13% | 51 |
|
2024
Q1 | $84M | Sell |
3,327,220
-437,000
| -12% | -$11M | 0.14% | 48 |
|
2023
Q4 | $87.9M | Sell |
3,764,220
-3,160
| -0.1% | -$73.8K | 0.2% | 42 |
|
2023
Q3 | $191M | Buy |
3,767,380
+300,000
| +9% | +$15.2M | 0.34% | 25 |
|
2023
Q2 | $162M | Buy |
3,467,380
+246,650
| +8% | +$11.5M | 0.28% | 32 |
|
2023
Q1 | $123M | Sell |
3,220,730
-23,185
| -0.7% | -$887K | 0.27% | 41 |
|
2022
Q4 | $178M | Buy |
3,243,915
+81,656
| +3% | +$4.47M | 0.69% | 32 |
|
2022
Q3 | $108M | Buy |
3,162,259
+542,588
| +21% | +$18.5M | 0.35% | 45 |
|
2022
Q2 | $24.8M | Buy |
2,619,671
+200,000
| +8% | +$1.89M | 0.07% | 84 |
|
2022
Q1 | $34.3M | Sell |
2,419,671
-60,000
| -2% | -$851K | 0.07% | 87 |
|
2021
Q4 | $52.4M | Hold |
2,479,671
| – | – | 0.1% | 91 |
|
2021
Q3 | $55.4M | Sell |
2,479,671
-10,023
| -0.4% | -$224K | 0.09% | 92 |
|
2021
Q2 | $61.8M | Sell |
2,489,694
-6,077
| -0.2% | -$151K | 0.09% | 87 |
|
2021
Q1 | $72.4M | Buy |
2,495,771
+208,141
| +9% | +$6.04M | 0.11% | 83 |
|
2020
Q4 | $59M | Buy |
2,287,630
+6,923
| +0.3% | +$179K | 0.1% | 85 |
|
2020
Q3 | $70.2M | Buy |
2,280,707
+1,282,333
| +128% | +$39.5M | 0.13% | 76 |
|
2020
Q2 | $24.9M | Buy |
998,374
+73,780
| +8% | +$1.84M | 0.06% | 95 |
|
2020
Q1 | $19.6M | Buy |
924,594
+485,000
| +110% | +$10.3M | 0.08% | 87 |
|
2019
Q4 | $9.76M | Sell |
439,594
-63,128
| -13% | -$1.4M | 0.04% | 80 |
|
2019
Q3 | $11.4M | Buy |
502,722
+281,722
| +127% | +$6.41M | 0.04% | 84 |
|
2019
Q2 | $4.23M | Buy |
+221,000
| New | +$4.23M | 0.02% | 99 |
|